Literature DB >> 16868817

Codeine and 6-acetylcodeine analgesia in mice.

Steven Milo1, Michael Ansonoff, Michael King, Grace C Rossi, Amy Zuckerman, John Pintar, Gavril W Pasternak.   

Abstract

1. Acetylation of morphine at the 6-position changes its pharmacology. To see if similar changes are seen with codeine, we examined the analgesic actions of codeine and 6-acetylcodeine. 2. Like codeine, 6-acetylcodeine is an effective analgesic systemically, supraspinally and spinally, with a potency approximately a third that of codeine. 3. The sensitivity of 6-acetylcodeine analgesia to the mu-selective antagonists beta-FNA and naloxonazine confirmed its classification as a mu opioid. However, it differed from the other mu analgesics in other paradigms. 4. Antisense mapping revealed the sensitivity of 6-acetylcodeine to probes targeting exons 1 and 2 of the mu opioid receptor gene (Oprm), a profile distinct from either codeine or morphine. Although heroin analgesia also is sensitive to antisense targeting exons 1 and 2, heroin analgesia also is sensitive to the antagonist 3-O-methylnaltrexone, while 6-acetylcodeine analgesia is not. 5. Thus, 6-acetylcodeine is an effective mu opioid analgesic with a distinct pharmacological profile.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868817     DOI: 10.1007/s10571-006-9101-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  28 in total

1.  Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F.

Authors:  Y X Pan; J Xu; E Bolan; A Chang; L Mahurter; G Rossi; G W Pasternak
Journal:  FEBS Lett       Date:  2000-01-28       Impact factor: 4.124

Review 2.  Animal models of nociception.

Authors:  D Le Bars; M Gozariu; S W Cadden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 25.468

3.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

4.  Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm.

Authors:  L Pan; J Xu; R Yu; M-M Xu; Y-X Pan; G W Pasternak
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors.

Authors:  G W Pasternak; S R Childers; S H Snyder
Journal:  Science       Date:  1980-05-02       Impact factor: 47.728

6.  Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1.

Authors:  A Zimprich; T Simon; V Höllt
Journal:  FEBS Lett       Date:  1995-02-13       Impact factor: 4.124

7.  Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.

Authors:  G C Rossi; G P Brown; L Leventhal; K Yang; G W Pasternak
Journal:  Neurosci Lett       Date:  1996-09-20       Impact factor: 3.046

8.  Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain.

Authors:  L A Bare; E Mansson; D Yang
Journal:  FEBS Lett       Date:  1994-11-07       Impact factor: 4.124

9.  Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor.

Authors:  K M Standifer; C C Chien; C Wahlestedt; G P Brown; G W Pasternak
Journal:  Neuron       Date:  1994-04       Impact factor: 17.173

10.  Classification of multiple morphine and enkephalin binding sites in the central nervous system.

Authors:  B L Wolozin; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  1 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.